↓ Skip to main content

ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib

Overview of attention for article published in Frontiers in oncology, January 2024
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
5 Mendeley